Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 +0.68% to 7320.53, DAX +0.15% to 15728.41, CAC40 +0.08% to 7246.62, STOXX 600 +0.39% to 453.45

Aug 23 ,2023

  • Synopsis:

    • European equity markets closed higher, however, well off best levels of the session. Just Austria, Belgium, Greece and Norway bucking the trend at the end of trading. US equities higher in midday trading. Treasuries stronger across the curve following some semblance of rate stabilization on Tuesday. Bund and Gilt yields down sharply data with moves in excess of 10 bps. Dollar index little changed with greenback lagging vs yen, little changed vs euro and stronger vs sterling. Gold up 1%. Bitcoin futures up 1.3% after finishing down in ten of the last eleven trading sessions. WTI crude down 0.8%, off worst levels after bigger crude draw than expected. Industrial metals higher. European gas prices sharply lower as Australia's Woodside meet unions meet for keys talks over LNG facilities. Defensive sectors the best performers. Utilities, Real Estate, Health Care, Telecom all the stronger; cyclicals lag with energy and retail the main decliners.

    • Eurozone PMIs came in focus today; euro area in contraction after German and French readings see big miss in services reading. Similar dynamic in UK PMIs with manufacturing weak and services now in contraction. The European Commission's latest consumer confidence reading showed a deterioration in sentiment with headline at (16.0) versus consensus (14.3) and prior (15.1). Consumer confidence in the bloc has improved since late last year and the August reading is the first weaker update since March. An update from UK human resource publication and data provider XpertHR said pay awards from UK firms eased for the first time this year in the quarter to July

    • Amidst light corporate news flow, in Health Care, spotlight on Bavarian Nordic A/S (BAVA.DC) big Q2 earnings beat, while FY23 guidance maintained. Roche (ROG.SW) published positive lung cancer drug trial data from an interim analysis, while GSK (GSK.LN) announced positive results from the first-ever efficacy trial of its preventative shingles treatment in China. Out of the Nordics, Mowi (MOWI.NO) reported Q2 numbers with underlying EPS €0.35 vs FactSet €0.37 along with a dividend of NOK2.00/share, while LSG.NO reported better Q2 performance. In Benelux, Agfa-Gevaert (AGFB.BB) traded lower post Q2 results with net income from cont. ops (€17M) vs year-ago (€20M); expects a recovery in FY23 profitability vs year-ago. Alfen (ALFEN.NA) was also down following Q2 report with adjusted EBITDA €8.4M vs FactSet €16.5M

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Real Estate +2.12%, Utilities +1.12%, Health Care +1.06%, Telecom +0.90%, Travel & Leisure +0.82%, Basic Resources +0.77%, Technology +0.73%, Food, Beverage and Tobacco +0.53%, Financial Svcs +0.48%, Insurance +0.44%

      • Underperformers:

        • Oil & Gas(1.09%), Retail (1.02%), Autos & Parts (0.47%), Banks (0.34%), Construct & Mtls (0.06%), Personal Care Drug and Grocery Stores +0.12%, Consumer Products and Services +0.19%, Chemicals +0.24%, Ind Goods & Svcs +0.39%

    • Macro:

      • Eurozone PMI weakest since November 2020, but wages remain a concern - Reuters, Bloomberg

      • Falling eurozone business activity raises doubts over ECB's next move - FT

      • UK:

        • UK-India trade talks enter 'final, trickier' stage, government sources - BBC

        • BoE warns on corporate default risk - FT

        • British small businesses see sales sink by 20% - Bloomberg

        • Sunak to delay cabinet reshuffle until later in year - London Times

      • European equities set for a better 2024 than this year, despite cheaper valuations -- Reuters poll

      • Russia offers to swap frozen assets with the west - FT

    • Peripheral markets:

      • Italy:

        • Local banks must be spared windfall tax says Tajani - ANSA

      • Spain:

      • Denmark

        • Danish consumer outlook worsens for first time in 10 months - Bloomberg

      • Greece

      • Iceland

    • Company news:

      • Notable Gainers

        • +18.2% CBRAIN.DC (cBrain DKK172.60, +26.60) -- H1 earnings

        • +13.7% KABE.B.SS (KABE Group SEK248.50, +30.00) -- H1 earnings

        • +11.4% ZAP.NO (Zaptec NOK32.74, +3.36) -- Q2 earnings

        • +10.8% LOGI.A.SS (Logistea SEK9.33, +0.91) -- signs 7-year lease agreement within the property Bofors 1:47 in Karlskoga

        • +8.0% BAVA.DC (Bavarian Nordic A/S DKK160.45, +11.85) -- Q2 earnings

        • +6.5% COST.LN (Costain Group £0.51, +0.03) -- H1 earnings

        • +6.3% LSG.NO (Lerøy Seafood Group NOK43.84, +2.60) -- Q2 earnings

        • +5.6% B2H.NO (B2Holding NOK6.92, +0.37) -- Q2 earnings

        • +5.5% CHRT.LN (Cohort £5.10, +0.27) -- contract

        • +4.3% SOBI.SS (Swedish Orphan Biovitrum SEK219.20, +9.00) -- terms of ~SEK 6.024B rights issue; Apellis Pharmaceuticals provides updates on rare safety events with SYFOVRE (pegcetacoplan injection)

        • +3.9% TNIE.GR (tonies €5.01, +0.19) -- Q2 revenue

        • +3.8% ROG.SW (Roche Holding CHF262.55, +9.50) -- been made aware of an inadvertent disclosure of the second interim analysis related to Phase III Skyscraper-01 study

        • +3.7% SALT.B.SS (SaltX Technology Holding SEK3.72, +0.13) -- Q2 earnings

        • +2.9% MOWI.NO (Mowi NOK184.90, +5.25) -- Q2 earnings

        • +2.1% GABR.DC (Gabriel Holding DKK384.00, +8.00) -- Q3 earningsx

      • Notable Decliners

        • -14.5% JAY.LN (Bluejay Mining £0.01, -0.00) -- raises £600K via private placement of 60.0M shares at 1.0p/share

        • -14.4% VOW.NO (Vow ASA NOK12.94, -2.18) -- H1 earnings

        • -9.8% ALFEN.NA (Alfen €51.60, -5.60) -- Q2 earnings

        • -6.6% NEXT.NO (Next Biometrics Group NOK5.36, -0.38) -- Q2 earnings

        • -6.5% EQT.SS (EQT AB SEK210.00, -14.60) -- EQT's top executives preparing to sell shares worth up to SEK 20B, or 7% of the company -- Dagens Industri

        • -6.3% ALFOC.FP (Focus Entertainment €35.15, -2.35) -- launch of Atlas Fallen, developed by Deck 13, is below initial forecasts

        • -5.7% GAPW.B.SS (Gapwaves SEK20.70, -1.25) -- Q2 earnings

        • -5.1% ALNG.NO (Awilco LNG NOK8.88, -0.48) -- Q2 earnings

        • -4.7% AMSC.NO (AMSC ASA NOK42.95, -2.10) -- Q2 earnings

        • -4.2% ORON.SW (ORIOR CHF72.70, -3.20) -- H1 earnings

        • -3.4% AGFB.BB (Agfa-Gevaert €2.26, -0.08) -- Q2 earnings

        • -3.2% SES.SS (Scandinavian Enviro Systems SEK1.34, -0.04) -- Q2 earnings

        • -3.2% SPG.DC (SP Group DKK211.00, -7.00) -- Q2 earnings

        • -2.8% GUBRA.DC (Gubra DKK104.00, -3.00) -- terminates collab with Bayer (BAYN.GR)

        • -2.7% ZEAL.DC (Zealand Pharma DKK268.40, -7.40) -- holder Danmarks Eksport- og Investeringsfond places 1.9M shares at DKK260/share

        • -2.6% AROC.SS (AroCell SEK0.50, -0.01) -- Q2 earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Tessenderlo (TESB.BB), Deceuninck (DECB.BB), Van Lanschot Kempen (VLK.NA),

        • France: Ramsay Generale de Sante (GDS.FP)

        • DACH: Swiss Prime Site (SPSN.SW), Kudelski (KUD.SW), Liechtensteinische Landesbank (LLBN.SW), SoftwareONE (SWON.SW), Molecular Partners (MOLN.SW), CTS Eventim & Co. (EVD.GR), Fielmann (FIE.GR), Einhell Germany (EIN3.GR), DATAGROUP (D6H.GR), Allane (LNSX.GR), Nabaltec (NTG.GR), NFON (NFN.GR), Multitude (FRU.GR), Schoeller-Bleckmann Oilfield Equipment (SBO.AV), Oberbank (OBS.AV), EVN (EVN.AV), UNIQA Insurance (UQA.AV)

        • Nordics: SalMar (SALM.NO), Norwegian Air Shuttle (NAS.NO), Crayon Group (CRAYN.NO), Froy (FROY.NO), Klaveness Combination Carriers (KCC.NO), Panoro Energy (PEN.NO), ECIT (ECIT.NO), SmartCraft (SMCRT.NO), Kid (KID.NO), SATS (SATS.NO), Odfjell Technology Ltd. (OTL.NO), Solstad Offshore (SOFF.NO), Integrated Wind Solutions (IWS.NO), Atlantic Sapphire (ASA.NO), Zalaris (ZAL.NO), Surgical Science Sweden (SUS.SS), Elekta (EKTA.B.SS), Hufvudstaden (HUFV.A.SS), Green Landscaping (GREEN.SS), Genovis (GENO.SS), Pagero Group (PAGERO.SS), Vicore Pharma (VICO.SS), Implantica (IMP.A.SS), Thunderful (THUNDR.SS), ALK-Abello (ALK.B.DC), Columbus (COLUM.DC), Gyldendal (GYLD.A.DC), Fynske Bank (FYNBK.DC), Nanoform Finland (NANOFH.FH), Keskisuomalainen (KSLAV.FH)

        • UK: Harbour Energy (HBR.LN), CRH (CRH.LN), Hays (HAS.LN), Hunting (HTG.LN), Benchmark (BMK.LN), Macfarlane (MACF.LN)

  • Data:

    • Economics:

      • Aug Flash Manufacturing PMI

        • Eurozone43.7 vs consensus 42.6 and prior 42.7

        • UK 42.5 vs consensus 45.0 and prior 45.3

        • France 46.4 vs consensus 45.0 and prior 45.1

        • Germany 39.1 vs consensus 38.7 and prior 38.8

      • Aug Flash Services PMI

        • Eurozone 48.3 vs consensus 50.5 and prior 50.9

        • UK 48.7 vs consensus 51.0 and prior 51.5

        • France 46.7 vs consensus 47.5 and prior 47.1

        • Germany 47.3 vs consensus 51.5 and prior 52.3

      • Eurozone Aug Flash Consumer Confidence (16.0) vs consensus (14.3) and prior (15.1)

    • Markets:

      • WTI Crude (Oct 23): ($0.70) or (0.88%) to $78.94

      • €-$ +0.0008 or +0.07% to 1.0856

      • £-$ (0.0022) or (0.17%) to 1.2710

      • €-£ +0.0023 to 0.8543

      • S&P 500 +0.89%

      • Performance year-to-date

        • FTSE 100: (1.76%)

        • DAX: +12.96%

        • CAC: +11.94%

        • MIB: +19.20%

        • Stoxx 600: +6.72%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE